RRML - AGT A-20C (rs5050) gene polymorphism and ulcer occurrence in patients treated with low-dose aspirin: a case-control study
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2020): 75%

Română English

Journal Metrics

Impact Factor 0.5
Five Year Impact Factor 0.5
JCI 0.12

Advanced search

Top 10 downloaded articles
- October 2025 -
 
Romanian Review of Laboratory ... 13
Comparison of platelet suspens... 12
Polymorphisms in FVL, prothrom... 11
The diagnostic value of lipopr... 10
Unlocking the future of breast... 10
Investigation of cytokine chan... 9
Serum fibronectin and C-reacti... 8
Plasma phosphorylated neurofil... 8
Evaluation of the impact of vi... 8
Oxidative stress in preeclamps... 8

Log in

Concept, Design & Programming
Dr. Adrian Man
   
 
Nr. 23(2)/2015 DOI:10.1515/rrlm-2015-0017
XML
TXT

AGT A-20C (rs5050) gene polymorphism and ulcer occurrence in patients treated with low-dose aspirin: a case-control study

Anca Negovan, Septimiu Voidăzan, Monica Pantea, Valeriu Moldovan, Simona Bataga, Laurentiu Cozlea, Simona Mocan, Claudia Banescu


Abstract:

Genetic factors may play a role in prediction of gastrointestinal side effects of aspirin, one of the most used drugs worldwide. We aim to determine a possible correlation between AGT A-20C (rs5050) gene polymorphism and gastro-duodenal ulcer in patients taking low-dose aspirin, adjusted for clinical and histological characteristics. Results. We enrolled 211 patients stratified according to AGT A-20C genotype: 122 AA, 83 AC and 6 CC patients. There were no significant differences regarding demographical and clinical parameters, except for the frequency of ulcers (4%, 8.4% respective 50%, p=0.03), endoscopic bleeding signs (12.3%, 14.5% respective 50%, p=0.0001) and the frequency of gastritis in biopsy (63.9%, 54.2% respective 16.7%, p=0.03) in genotype groups. When we compared ulcer and non-ulcer group, variant homozygous CC genotype carried an increased risk for ulcer (OR:9.66, 95% CI: 1.46-63.7, p=0.04) than AA group, as well as variant C allele compared with normal A allele (OR: 2.12, 95% CI: 1.07-4.63, p=0.04). On multivariate analysis, variant homozygous CC genotype AGT A-20C showed an OR: 12.32 (95% CI:1.40 -108.13, p=0.02) for ulcer, while H. pylori infection (OR:2.40, 95% CI:1.18 -6.54, p=0.04) and concurrent use of non-steroidal anti-inflammatory drugs (NSAIDs) (OR:1.31, 95% CI:1.07 - 2.27, p=0.05) remained predictors for ulcer in aspirin consumers. Conclusions. Variant C allele and variant homozygous CC genotype AGT A-20C, infection with H. pylori and NSAIDs co-treatment are risk factors for gastro-duodenal ulcer in low-dose aspirin consumers. The variant homozygous CC genotype AGT A-20C patients treated with LDA are more prone to have reactive gastropathy and bleeding ulcers in a population with a high prevalence of H. pylori infection.

Keywords: AGT A-20C (rs5050) gene polymorphism;low-dose aspirin;gastro-duodenal ulcer;H. pylori;reactive gastropathy

Received: 14.12.2014
Accepted: 18.5.2015
Published: 4.6.2015

 
  PDF Download full text PDF
(427 KB)
     
 
How to cite
Negovan A, Voidăzan S, Pantea M, Moldovan V, Bataga S, Cozlea L, et al. AGT A-20C (rs5050) gene polymorphism and ulcer occurrence in patients treated with low-dose aspirin: a case-control study. Rev Romana Med Lab. 2015;23(2):179-87. DOI:10.1515/rrlm-2015-0017